Artificial breast prosthesis delivery device

Abstract

One embodiment of the present specification provides an artificial breast prosthesis delivery device comprising: a tapered body which is formed of a polyurethane material having a Shore A hardness (measured according to ASTM D2240) of 60-100 and has a width gradually decreasing from one side to the other side; and a plurality of vertical grooves which are recessed in the inner surface of the body, extend from one side to the other side, and are radially spaced apart from each other.

Description

Breast implant delivery device

[0001] This specification relates to an artificial breast implant delivery device.

[0002] Breast implants are products that consistently cause side effects such as inflammation, capsular contracture, and rupture, and among these, a representative problem is the occurrence of side effects due to the rupture of breast implants. When a breast implant ruptures, the gel or saline solution filled inside the implant may leak out, and the leaked gel or saline solution can cause inflammation in body tissues or organs, or lead to various serious side effects such as complications or tissue necrosis.

[0003] Rupture of such breast implants occurs due to various causes, among which it is frequently caused by stress or stress concentration on the outer shell of the implant.

[0004] Artificial breast implants are inserted into the body by making an incision in the skin tissue during breast augmentation surgery; however, if the skin tissue is incised too large during the surgery, not only is the skin at the incision site damaged, but scarring and complications may also occur.

[0005] Therefore, artificial breast implants are often inserted through a narrow incision; as they pass through this confined space, significant stress concentrates on the shell, causing stress that can lead to rupture.

[0006] Accordingly, the tapered artificial breast implant delivery device (T) of Fig. 1, which can minimize the incision site when implanting the implant, is gaining popularity. Since the implant (B) can be implanted into the body through a narrowing structure, it is possible to implant with a minimal incision, and there are advantages such as reduced risk of infection and reduced surgery time and recovery time.

[0007] However, due to the structure of the tapered artificial breast implant delivery device (T), a large injection force is required for the implant (B) to pass through the narrow opening (T1), and there is a concern that if such an injection force is applied to the implant, side effects may occur due to the rupture of the implant.

[0008] In addition, conventional tapered breast implant delivery devices are formed from high-hardness and rigid polyvinyl chloride (PVC) material, which has a problem in that force is not easily transmitted when breast implants are injected.

[0009] Therefore, it is necessary to develop technology that can reduce the injection force required for breast implant surgery while simultaneously minimizing the stress applied to the implant.

[0010] The details of this specification are intended to solve the problems of the aforementioned prior art, and one objective of this specification is to provide a tapered breast implant delivery device that can reduce the injection force required when implanting the breast implant, thereby minimizing the stress applied to the implant.

[0011] According to one aspect, an artificial breast implant delivery device is provided, comprising: a tapered body formed of a polyurethane material having a Shore A hardness (measured according to ASTM D2240) of 60 to 100, which narrows in width from one side to the other; and a plurality of longitudinal grooves formed by being recessed into the inner surface of the body, extending from one side to the other, and arranged radially spaced apart from each other.

[0012] In one embodiment, the polyurethane may be a thermosetting polyurethane or a thermoplastic polyurethane.

[0013] In one embodiment, the polyurethane may be prepared by mixing a polyol and a diisocyanate in a molar ratio of 1:1 to 1:3.

[0014] In one embodiment, the thickness of the body may be 0.1 to 1.0 mm.

[0015] In one embodiment, the groove spacing between the vertical groove and the adjacent vertical groove may become narrower from one side to the other.

[0016] In one embodiment, the groove spacing at one end of the vertical groove may be 0.15 mm or more and 100 mm or less, and the groove spacing at the other end of the vertical groove may be 0.025 mm or more and 50 mm or less.

[0017] In one embodiment, the depth of the longitudinal groove may be 0.01 mm or more and 0.15 mm or less.

[0018] In one embodiment, the length of the vertical groove may be 100 mm or more and 400 mm or less.

[0019] In one embodiment, the vertical grooves may be arranged at equal intervals with adjacent vertical grooves.

[0020] In one embodiment, the body may be formed as a hollow structure such that a first opening at one end is larger than a second opening at the other end.

[0021] In one embodiment, a lubricant may be applied to the inner surface of the body.

[0022] In one embodiment, the lubricant may be one selected from the group consisting of oil, saline solution, hydrophilic lubricant, and a combination of two or more of these.

[0023] An artificial breast implant delivery device according to one aspect of the present specification can reduce the injection force required during the implantation of an artificial breast implant, thereby minimizing stress applied to the implant and, accordingly, preventing adverse effects caused by the rupture of the artificial breast implant.

[0024] The effects of one aspect of this specification are not limited to the effects described above, and should be understood to include all effects that can be inferred from the configurations described in the detailed description or claims of this specification.

[0025] Figure 1 is a schematic diagram showing a tapered breast implant delivery device.

[0026] FIG. 2 is a schematic diagram showing a tapered artificial breast implant delivery device including a longitudinal groove according to one embodiment of the present invention.

[0027] FIG. 3 is a schematic cross-sectional view of a tapered breast implant delivery device including a longitudinal groove with the other end removed.

[0028] FIG. 4 is a schematic diagram showing a portion of a cross-sectional view of a tapered breast implant delivery device including the longitudinal groove of FIG. 2.

[0029] [Explanation of the symbol]

[0030] 1 Tapered breast implant delivery device including a longitudinal groove

[0031] 10 bodies

[0032] 20 vertical grooves

[0033] Hereinafter, one aspect of the present specification will be described with reference to the attached drawings. However, the details described in the present specification may be implemented in various different forms and are therefore not limited to the embodiments described herein. Furthermore, in order to clearly explain one aspect of the present specification in the drawings, parts unrelated to the explanation have been omitted, and similar parts throughout the specification have been given similar reference numerals.

[0034] Throughout the specification, when a part is described as "including" a certain component, this means that, unless specifically stated otherwise, it does not exclude other components but rather allows for the inclusion of additional components.

[0035] Terms including ordinal numbers such as ‘first’ or ‘second’ used herein may be used to describe various components or steps, but such components or steps should not be limited by ordinal numbers. Terms including ordinal numbers should be interpreted solely for the purpose of distinguishing one component or step from other components or steps.

[0036] When a range of numerical values ​​is described in this specification, unless a specific range is otherwise described, the value has the precision of significant figures provided according to the standard rules in chemistry for significant figures. For example, 10 includes a range of 5.0 to 14.9, and the number 10.0 includes a range of 9.50 to 10.49.

[0037] Hereinafter, an embodiment of the present specification will be described in detail with reference to the attached drawings.

[0038] Breast implant delivery device

[0039] An artificial breast implant delivery device according to one aspect of the present specification comprises: a tapered body formed of a polyurethane material having a Shore A hardness (measured according to ASTM D2240) of 60 to 100, which narrows in width from one side to the other; and a plurality of longitudinal grooves formed by being recessed into the inner surface of the body, extending from one side to the other, and arranged radially spaced apart from each other.

[0040] The above-described artificial breast implant delivery device is configured to deliver an artificial breast implant to a surgical pocket. Here, the surgical pocket refers to an incision site such as the patient's armpit or under the breast.

[0041] Conventional tapered breast implant delivery devices are formed from high-hardness and rigid polyvinyl chloride (PVC) material, so there was a problem where force was not easily transmitted during breast implant injection, requiring greater force.

[0042] The above-mentioned artificial breast implant delivery device is formed of a polyurethane material with a Shore A hardness (measured according to ASTM D2240) of 60 to 100, which can reduce the injection force required when injecting the artificial breast implant and minimize the stress applied to the implant when implanting the artificial breast implant, thereby preventing side effects caused by the rupture of the artificial breast implant.

[0043] The above polyurethane may be a polyurethane elastomer.

[0044] The above polyurethane may be a thermosetting polyurethane or a thermoplastic polyurethane (TPU), and preferably may be a thermoplastic polyurethane.

[0045] The Shore A hardness of the polyurethane material, measured by the durometer hardness test method according to ASTM D2240, may be 60 to 100. For example, it may be 60, 65, 70, 75, 80, 85, 90, 95, 100, or a range between two of these values. If the Shore A hardness of the polyurethane material is below the above range, the breast implant delivery device may tear before implantation due to low fracture strength, making implantation impossible; if it exceeds the above range, the hardness may be too high, causing the breast implant delivery device to become rigid, and consequently, the injection force required for implantation of the breast implant may increase.

[0046] The above polyurethane is a polymer compound containing urethane bonds formed by the addition reaction of a polyol having a hydroxyl group (-OH) and a diisocyanate having an isocyanate group (-NCO). The hardness and elasticity of the above polyurethane may vary depending on the mixing ratio of the polyol and the diisocyanate, and accordingly, the injection force required when injecting an artificial breast implant may vary.

[0047] The above polyurethane may be prepared by mixing a polyol and a diisocyanate in a molar ratio of 1:1 to 1:3. That is, the NCO / OH ratio of the polyol and the diisocyanate may be 1 to 3. For example, it may be 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3, or a range between two of these values. If the NCO / OH ratio is below the above range, the breast implant delivery device may tear before implant injection due to low fracture strength, making implant injection impossible; if it exceeds the above range, the hardness increases, causing the breast implant delivery device to become too rigid, and consequently, the injection force required for breast implant implantation may increase.

[0048] The thickness of the body may be 0.1 to 1.0 mm. For example, it may be 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1.0 mm, or a range between two of these values. If the thickness of the body is less than the above range, the breast implant delivery device may tear before the implant is injected due to low breaking strength, making implant injection impossible; if it exceeds the above range, a very large force may be required to inject the implant due to the high elasticity of the breast implant delivery device.

[0049] The above-described artificial breast implant delivery device may include a plurality of longitudinal grooves that are formed by being recessed into the inner surface of the body, extend from one side to the other, and are arranged radially spaced apart from each other. That is, the above-described artificial breast implant delivery device may be a tapered type artificial breast implant delivery device including longitudinal grooves. When using a tapered type artificial breast implant delivery device including longitudinal grooves, the stress applied to the implant during implantation of the artificial breast implant can be further reduced, thereby preventing side effects caused by the rupture of the artificial breast implant.

[0050] FIG. 2 is a schematic diagram showing a tapered artificial breast implant delivery device including a longitudinal groove according to one embodiment of the present invention.

[0051] Referring to FIG. 2, the tapered artificial breast implant delivery device (1) including the longitudinal groove comprises a body (10) and a longitudinal groove (20).

[0052] The tapered breast implant delivery device (1) including the above-mentioned longitudinal groove may include a tapered body (10) in which an artificial breast implant is received and which becomes narrower from one side to the other; and a plurality of longitudinal grooves (20) formed by being recessed into the inner surface of the body, extending from one side to the other, and arranged radially spaced apart from each other.

[0053] In detail, the body (10) is formed such that the width of the body (10) narrows as it extends toward the other end (12), and a first opening (11) into which an implant is inserted is formed at one end. The pointed other end (12) of the body (10) may be cut off during the implant surgery. In this case, a second opening (13) into which the implant can be discharged may be formed at the other end of the body (10), and the second opening (13) is formed to be smaller than the first opening (11).

[0054] For example, the body (10) may be tapered, conical, or funnel-shaped. Alternatively, the body (10) may be pyramid-shaped. However, it is not limited thereto, and the body (10) may be provided with a hollow structure in which one side opening, i.e., a first opening (11) at one end, is larger than the other side opening, i.e., a second opening (13) at the other end. In this way, the body (10) may be applied in various shapes in which its width narrows from one side to the other.

[0055] Due to the tapered structure of the body (10), when the operator applies a load to the body (10), the implant can slide along the narrowing inner surface of the body (10) and move into the surgical pocket.

[0056] FIG. 3 is a schematic cross-sectional view of a tapered breast implant delivery device including a longitudinal groove with the other end removed.

[0057] Referring to FIG. 3, the vertical groove (20) is formed by being recessed to a certain depth on the inner surface of the body (10) and extends from one side of the body (10) to the other side, that is, in the direction of injection of the implant or the direction in which a load is applied.

[0058] Here, if the groove is formed in a horizontal direction perpendicular to the injection direction of the implant, the load is distributed along the groove, so the effect of the load being transmitted from the first opening (11) to the second opening (13), i.e., stress concentration, is reduced, and instead, only the frictional force is increased by the groove, so the load required for implantation may increase.

[0059] The vertical grooves (20) may be formed in multiple numbers along the circumference of the body (10) and may be spaced apart from each other in a horizontal direction. Specifically, the vertical grooves (20) may be formed in multiple numbers spaced apart at equal intervals radially with respect to the center of the body (10). That is, the vertical grooves (20) may be formed at regular intervals along the circumference of the body (10).

[0060] The groove spacing, which is the horizontal spacing between the vertical groove (20) and the adjacent vertical groove (20) of the artificial breast implant delivery device, can be formed to become narrower from one side to the other.

[0061] FIG. 4 is a schematic diagram showing a portion of a cross-sectional view of a tapered breast implant delivery device including the longitudinal groove of FIG. 2.

[0062] Referring to FIGS. 2 and 4, the groove spacing (d1) on the side of the first opening (11), that is, the groove spacing (d1) at one end (21) of the vertical groove (20), can be formed to be 0.15 mm or more and 100 mm or less, and the groove spacing (d2) on the side of the second opening (13), that is, the groove spacing (d2) at the other end (22) of the vertical groove (20), can be formed to be 0.025 mm or more and 50 mm or less. Here, the groove spacing (d1) on the side of the first opening (11) can be formed to be larger than the groove spacing (d2) on the side of the second opening (13).

[0063] If the groove spacing (d1) at one end (21) of the vertical groove (20) is less than 0.15 mm, or the groove spacing (d2) at the other end (22) of the vertical groove (20) is less than 0.025 mm, the strength of the body (10) is weakened and it may tear. In addition, if the groove spacing (d1) at one end (21) of the vertical groove (20) exceeds 100 mm, or the groove spacing (d2) at the other end (22) of the vertical groove (20) exceeds 50 mm, the reduction in surface area is weak, stress concentration is reduced, and the effect of reducing injection force does not appear.

[0064] In one embodiment, the depth (d3) of the vertical groove (20) may be formed to be 0.01 mm or more and 0.15 mm or less.

[0065] If the depth (d3) of the vertical groove (20) is less than 0.01 mm, when a load is applied, the vertical groove (20) spreads out and disappears, so the effect of stress concentration can be eliminated. If the depth (d3) of the vertical groove (20) exceeds 0.15 mm, the implant is inserted between the vertical groove (20), increasing the contact area between the body (10) and the implant, and as a result, the frictional force increases, so stress concentration can be inhibited.

[0066] In one embodiment, the length (d4) of the vertical groove (20) may be formed to be 100 mm or more and 400 mm or less.

[0067] A lubricant may be applied to the inner surface of the body. By applying a lubricant to the inner surface of the artificial breast implant delivery device, the frictional force on the inner surface of the body is reduced, thereby reducing the injection force required when injecting the artificial breast implant. Additionally, the stress applied to the implant during implantation can be minimized, and consequently, side effects caused by the rupture of the artificial breast implant can be prevented.

[0068] The above lubricant may be one selected from the group consisting of oil, saline solution, hydrophilic lubricant, and a combination of two or more of these.

[0069] The above oil may be natural oil or silicone oil, but is not limited thereto, and any oil that can be applied to an artificial breast implant delivery device may be used regardless of type.

[0070] The above natural oil may be an oil extracted from natural substances such as plants, and may be extracted by conventional extraction methods, but is not limited thereto.

[0071] The above natural oil may be an oleic acid-based natural oil or a terpene-based essential oil, but is not limited thereto.

[0072] The above natural oil may be one selected from the group consisting of aroma oil, olive oil, soybean oil, camellia oil, grapeseed oil, sunflower oil, macadamia nut oil, avocado oil, jojoba oil, coconut oil, mandarin oil, tea tree oil, palmarosa oil, evening primrose oil, lavender oil, and combinations of two or more of these, but is not limited thereto.

[0073] The above silicone oil may be a silicone oil containing a siloxane series, and, for example, a silicone series similar to the main material of artificial breast implants may be used, but is not limited thereto.

[0074] The above hydrophilic lubricant may be a substance having a hydrophilic functional group such as hyaluronic acid (HA), cellulose, glycerol, ethylene glycol, and sulfonic acid, but is not limited thereto.

[0075] The above hydrophilic lubricant may be one selected from the group consisting of cellulose, hyaluronic acid, propylene glycol, glycerol, 4,4'-diaminostibene-2,2'-disulfonic acid (DASDA), 2'-deoxyadenosine 5'-monophosphate (DAP), 2'-deoxycytidine 5'-monophosphate (DCP), N-Tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid (TAPS), and combinations of two or more of these, but is not limited thereto.

[0076] The above lubricant can be applied to the inner surface of the artificial breast implant delivery device by methods such as application or coating.

[0077] The embodiments of this specification will be described in more detail below. However, the following experimental results represent only representative results among the above embodiments, and the scope and content of this specification should not be interpreted as being narrowed or limited by the embodiments. The respective effects of various embodiments of this specification not explicitly presented below will be described in detail in the relevant sections.

[0078] Example 1

[0079] A tapered breast implant delivery device having a thickness of 0.1 mm and a longitudinal groove on the inner surface of the body was manufactured using a polyurethane material that is prepared by mixing polyol and diisocyanate in a molar ratio of 1:3 and has a Shore A hardness of 100 as measured by the durometer hardness test method according to ASTM D2240.

[0080] The longitudinal groove was formed with a length of 250 mm, a groove spacing of 50 mm at one end and 20 mm at the other end, and a depth of 0.01 mm. A hydrophilic lubricant was uniformly applied to the inner surface of the tapered breast implant delivery device containing the manufactured longitudinal groove.

[0081] Example 2

[0082] A tapered breast implant delivery device including a longitudinal groove was manufactured in the same manner as in Example 1, except that a polyurethane material was used, which is prepared by mixing polyol and diisocyanate in a molar ratio of 1:1.5 and has a Shore A hardness of 80 as measured according to ASTM D2240.

[0083] Example 3

[0084] A tapered breast implant delivery device including a longitudinal groove was manufactured in the same manner as in Example 1, except that a polyurethane material was used, which is prepared by mixing polyol and diisocyanate in a molar ratio of 1:1 and has a Shore A hardness of 60 as measured according to ASTM D2240.

[0085] Example 4

[0086] A tapered breast implant delivery device including a longitudinal groove was manufactured in the same manner as in Example 2 above, except that the thickness is 0.5 mm.

[0087] Example 5

[0088] A tapered breast implant delivery device including a longitudinal groove was manufactured in the same manner as Example 2 above, except that the thickness is 1.0 mm.

[0089] Comparative Example 1

[0090] A tapered breast implant delivery device including a longitudinal groove was manufactured in the same manner as in Example 1, except that a polyvinyl chloride material with a Shore A hardness of 100 as measured according to ASTM D2240 was used.

[0091] Comparative Example 2

[0092] A tapered breast implant delivery device including a longitudinal groove was manufactured in the same manner as in Example 1, except that a polyvinyl chloride material with a Shore A hardness of 80 as measured according to ASTM D2240 was used.

[0093] Experimental Example 1

[0094] In order to verify the change in injection force according to the material and hardness of the artificial breast implant delivery device, the injection force, which is the magnitude of the maximum force required to inject the artificial breast implant in the artificial breast implant delivery devices of Examples 1 to 3 and Comparative Examples 1 and 2, was measured. The results are shown in Table 1 below.

[0095] Specifically, using a universal testing machine from INSTRON, the artificial breast implant was injected from the first opening to the second opening at a constant speed (100 mm / min) within the artificial breast implant delivery device, and the maximum load applied to the universal testing machine was measured as the injection force.

[0096] Classification Material Shore A Hardness Thickness (mm) Main Input (N) Example 1 Polyurethane 1000.190 Example 2 Polyurethane 800.180 Example 3 Polyurethane 600.168 Comparative Example 1 Polyvinyl Chloride 1000.1100 Comparative Example 2 Polyvinyl Chloride 800.198

[0097] Referring to Table 1 above, it was confirmed that the artificial breast implant delivery devices of Examples 1 to 3, manufactured using polyurethane material, require a lower injection force when injecting the artificial breast implant compared to the artificial breast implant delivery devices of Comparative Examples 1 and 2, manufactured using polyvinyl chloride material. In particular, it was confirmed that the injection force of the artificial breast implant delivery devices of Examples 1 to 3, manufactured using polyurethane material, decreased as the hardness of the material decreased, whereas the difference in injection force according to the hardness of the material of the artificial breast implant delivery devices of Comparative Examples 1 and 2, manufactured using polyvinyl chloride material, was very small.

[0098] Experimental Example 2

[0099] In order to verify the change in injection force according to the thickness of the artificial breast implant delivery device, the injection force, which is the magnitude of the maximum force required to inject the artificial breast implant in the artificial breast implant delivery devices of Examples 2, 4, and 5, was measured in the same manner as in Experimental Example 1. The results are shown in Table 2 below.

[0100] Classification Material Shore A Hardness Thickness (mm) Main Input (N) Example 2 Polyurethane 800.180 Example 4 Polyurethane 800.586 Example 5 Polyurethane 801.092

[0101] Referring to Table 2 above, it was confirmed that the injection force required for breast implant injection decreases as the thickness of the breast implant delivery device decreases. However, when the thickness of the breast implant delivery device was less than 0.1 mm, the breast implant delivery device tore before the implant was injected due to low fracture strength, making implant injection impossible.

[0102] Experimental Example 3

[0103] In order to confirm the relationship between the elastic force and the injection force of the artificial breast implant delivery device, the elastic modulus of the artificial breast implant delivery device of Examples 1 to 5 was measured through the slope of the SS curve (Stress-Strain curve) obtained through a tensile test. The results are shown in Table 3 below.

[0104] Classification Shore A Hardness Thickness (mm) Main Input (N) Elastic Modulus Example 1 1000.19027 Example 2 800.18013 Example 3 600.16810 Example 4 800.58614 Example 5 801.09217

[0105] Referring to Table 3 above, it was confirmed that the smaller the elastic modulus of the breast implant delivery device, the easier the force transmission becomes, and thus the injection force required for breast implant injection tends to decrease. Meanwhile, when the thickness of the breast implant delivery device exceeded 1.0 mm, a very large force was required for implant injection due to the high elasticity of the breast implant delivery device.

[0106] The foregoing description of this specification is for illustrative purposes only, and those skilled in the art to which one aspect of this specification pertains will understand that other specific forms can be easily modified without altering the technical concept or essential features described in this specification. Therefore, the embodiments described above should be understood as illustrative in all respects and not restrictive. For example, each component described as a single unit may be implemented in a distributed manner, and components described as distributed may likewise be implemented in a combined form.

[0107] The scope of this specification is defined by the claims set forth below, and all modifications or variations derived from the meaning and scope of the claims and equivalent concepts thereof should be interpreted as being included within the scope of this specification.

Claims

1. A tapered body formed of a polyurethane material having a Shore A hardness (measured according to ASTM D2240) of 60 to 100, with the width narrowing from one side to the other; and An artificial breast implant delivery device comprising: a plurality of longitudinal grooves formed by being recessed into the inner surface of the body, extending from one side to the other, and arranged radially spaced apart from each other.

2. In Paragraph 1, An artificial breast implant delivery device in which the above-mentioned polyurethane is a thermosetting polyurethane or a thermoplastic polyurethane.

3. In Paragraph 1, The above-mentioned polyurethane is an artificial breast implant delivery device manufactured by mixing a polyol and a diisocyanate in a molar ratio of 1:1 to 1:

3.

4. In Paragraph 1, An artificial breast implant delivery device having a body thickness of 0.1 to 1.0 mm.

5. In Paragraph 1, An artificial breast implant delivery device in which the groove spacing between the above-mentioned longitudinal groove and an adjacent longitudinal groove becomes narrower from one side to the other.

6. In Paragraph 5, The groove spacing at one end of the above-mentioned vertical groove is 0.15 mm or more and 100 mm or less, and An artificial breast implant delivery device in which the groove spacing at the other end of the above-mentioned longitudinal groove is 0.025 mm or more and 50 mm or less.

7. In Paragraph 1, An artificial breast implant delivery device having a longitudinal groove depth of 0.01 mm or more and 0.15 mm or less.

8. In Paragraph 1, An artificial breast implant delivery device having a longitudinal groove length of 100 mm or more and 400 mm or less.

9. In Paragraph 1, The above-mentioned longitudinal grooves are arranged at equal intervals with adjacent longitudinal grooves, forming an artificial breast implant delivery device.

10. In Paragraph 1, The above body is a hollow structure, and the first opening at one end is formed to be larger than the second opening at the other end, an artificial breast implant delivery device.

11. In Paragraph 1, An artificial breast implant delivery device in which a lubricant is applied to the inner surface of the above body.

12. In Paragraph 11, An artificial breast implant delivery device in which the above lubricant is one selected from the group consisting of oil, saline solution, hydrophilic lubricant, and a combination of two or more of these.

Images